[1]
2024. 37. CLINICAL FEATURES, SUBCLINICAL CHARACTERISTICS AND RESULTS OF TARGET TREATMENT OF NON-SMALL CELL LUNG CANCER PATIENTS WITH DOUBLE MUTATIONS OF THE EGFR GENE PERIOD 2019-2023. Vietnam Journal of Community Medicine. 65, CĐ 3 - Bệnh viện Phổi Trung ương (May 2024). DOI:https://doi.org/10.52163/yhc.v65iCD3.1134.